Orexigen puts obesity drug development on hold

Shares of Orexigen tanked after they revealed they are halting work on FDA approval of their anti-obesity drug Contrave. 

http://finance.yahoo.com/news/Orexigen-puts-obesity-drug-apf-2428062223.html?x=0&.v=3

FDA declines to approve Orexigen diet drug

http://finance.yahoo.com/news/FDA-declines-to-approve-apf-1752455254.html?x=0&.v=11

Arena plunges, blames FDA panel over obesity drug

http://www.reuters.com/article/idUSTRE68G2CF20100917